10x Genomics (TXG) P/E ratio

There is no P/E ratio history on record here for 10x Genomics (TXG). Figures as of 18 Nov 2026, 09:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/E ratio needs at least 3 fiscal years; none is on record here for 10x Genomics. Nothing is estimated to fill the gap. What is on record is in the table below.

10x Genomics P/E ratio, year by year

10x Genomics (TXG) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$16.31-$0.35
2024——$14.36-$1.52
2023——$55.96-$2.18
2022——$36.44-$1.46
2021——$148.96-$0.53
2020——$141.60-$5.37
2019——$76.25-$0.80

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of 10x Genomics and comparable companies
CompanyP/E ratio
Protagonist Therapeutics PTGX26.4×
Krystal Biotech KRYS40.6×
HealthEquity HQY36.8×
Corcept Therapeutics CORT52.7×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics P/E ratio: questions and answers

How is 10x Genomics's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/TXG/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.